Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of “Hold” from Analysts

Shares of Smith & Nephew plc (NYSE:SNN) have received a consensus rating of “Hold” from the six brokerages that are covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a hold rating. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $28.00.

Several brokerages have commented on SNN. UBS Group lowered Smith & Nephew from a “buy” rating to a “neutral” rating in a research note on Wednesday, March 12th. Hsbc Global Res cut shares of Smith & Nephew from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 25th. StockNews.com raised shares of Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, February 26th. HSBC cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, April 25th. Finally, Canaccord Genuity Group raised their price objective on Smith & Nephew from $27.00 to $28.00 and gave the company a “hold” rating in a research report on Thursday.

Smith & Nephew Trading Up 0.9 %

SNN stock opened at $28.26 on Friday. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The company has a market cap of $12.38 billion, a price-to-earnings ratio of 13.08, a PEG ratio of 1.26 and a beta of 0.71. The business has a fifty day simple moving average of $27.64 and a 200-day simple moving average of $26.33. Smith & Nephew has a 52 week low of $23.69 and a 52 week high of $31.72.

Smith & Nephew Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Friday, March 28th will be issued a $0.447 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a yield of 2.5%. This is a positive change from Smith & Nephew’s previous semi-annual dividend of $0.29. Smith & Nephew’s payout ratio is currently 41.20%.

Institutional Trading of Smith & Nephew

Several large investors have recently modified their holdings of the business. Sei Investments Co. boosted its holdings in Smith & Nephew by 229.8% in the fourth quarter. Sei Investments Co. now owns 75,215 shares of the medical equipment provider’s stock valued at $1,849,000 after purchasing an additional 52,411 shares during the last quarter. Townsquare Capital LLC boosted its stake in shares of Smith & Nephew by 19.0% during the 4th quarter. Townsquare Capital LLC now owns 17,557 shares of the medical equipment provider’s stock valued at $432,000 after buying an additional 2,798 shares during the last quarter. Blue Trust Inc. grew its position in shares of Smith & Nephew by 26.0% during the fourth quarter. Blue Trust Inc. now owns 5,871 shares of the medical equipment provider’s stock worth $144,000 after buying an additional 1,213 shares in the last quarter. ABC Arbitrage SA bought a new stake in shares of Smith & Nephew in the fourth quarter worth $4,847,000. Finally, GAMMA Investing LLC boosted its stake in Smith & Nephew by 31.8% during the 4th quarter. GAMMA Investing LLC now owns 2,975 shares of the medical equipment provider’s stock valued at $73,000 after acquiring an additional 718 shares during the last quarter. 25.64% of the stock is currently owned by institutional investors and hedge funds.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.